PROCEPT BioRobotics Corp. (PRCT)
22.76
+1.39
(+6.50%)
USD |
NASDAQ |
Sep 04, 16:00
22.44
-0.32
(-1.41%)
After-Hours: 20:00
PROCEPT BioRobotics Research and Development Expense (Quarterly) : 20.10M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.10M |
| March 31, 2026 | 21.46M |
| December 31, 2025 | 19.06M |
| September 30, 2025 | 16.57M |
| June 30, 2025 | 16.04M |
| March 31, 2025 | 16.40M |
| December 31, 2024 | 15.07M |
| September 30, 2024 | 15.32M |
| June 30, 2024 | 16.23M |
| March 31, 2024 | 11.90M |
| December 31, 2023 | 13.18M |
| September 30, 2023 | 10.55M |
| Date | Value |
|---|---|
| June 30, 2023 | 11.15M |
| March 31, 2023 | 9.449M |
| December 31, 2022 | 9.682M |
| September 30, 2022 | 6.141M |
| June 30, 2022 | 6.085M |
| March 31, 2022 | 5.011M |
| December 31, 2021 | 5.076M |
| September 30, 2021 | 4.919M |
| June 30, 2021 | 3.705M |
| March 31, 2021 | 4.522M |
| December 31, 2020 | 4.543M |
| September 30, 2020 | 3.893M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insulet Corp. | 88.10M |
| Globus Medical, Inc. | 36.32M |
| Abbott Laboratories | 892.00M |
| Alphatec Holdings, Inc. | 18.17M |
| Artivion, Inc. | 9.055M |